>
pdufa.bio

Bulevirtide

Updated ยทnext FDA decision on the calendar

Bulevirtide is a Vir Biotechnology, Inc. program. Its next catalyst is a Readout in Nov 2026. Every date links its source.

VIR catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Vir Biotechnology, Inc. (VIR). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Nov 2026VIR

Questions

When is Bulevirtide's next FDA decision or readout?

The next tracked catalyst for Bulevirtide is a Readout in Nov 2026.

What happened at Bulevirtide's most recent FDA decision?

No FDA decision for Bulevirtide is in our archive yet.

Who makes Bulevirtide?

Vir Biotechnology, Inc. (VIR).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.